Skip to main content
logo
XORTX Therapeutics Inc. (XRTX)
0.3791
+0.0341 (9.88%)
Inactive · Last trade price on Mar 27, 2026

XORTX Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
34441223
Market Cap Growth
261.13%-8.88%1.60%-65.60%-48.16%-
Enterprise Value
1.7531.690.881.979.66

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.231.871.230.941.771.94
P/TBV Ratio
0.381.921.541.292.191.89

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0000.000
Net Debt / Equity Ratio
-0.18-0.40-0.73-0.74-1.48-1.13
Net Debt / EBITDA Ratio
0.080.260.610.581.015.15
Net Debt / FCF Ratio
0.090.300.660.521.263.11
Quick Ratio
0.180.822.753.166.9626.97
Current Ratio
0.441.092.963.677.2128.78
Return on Equity (ROE)
-164.30%-98.00%-83.06%-37.08%-76.28%-22.20%
Return on Assets (ROA)
-129.14%-96.13%-86.13%-67.77%-69.04%-30.27%
Return on Invested Capital (ROIC)
-216.87%-223.42%-287.26%-800.78%-1363.21%-401.38%
Return on Capital Employed (ROCE)
-316.59%-138.04%-109.12%-79.44%-74.19%-32.58%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-64.48%-64.48%-45.25%-33.91%-35.25%-47.77%
Total Shareholder Return
-64.48%-64.48%-45.25%-33.91%-35.25%-47.77%
SEC Filings: 10-K · 10-Q